Dr Joshua Bennetts
Postdoctoral Researcher
School of Medicine and Public Health
- Email:joshua.bennetts@newcastle.edu.au
- Phone:0435943292
Career Summary
Biography
Dr Joshua Bennetts is a clinical academic pharmacist and postdoctoral researcher from the Newcastle Centre of Excellence in Cardio-Oncology. Joshua completed his Bachelor of Pharmacy with First Class Honours in 2018 and received his general pharmacist registration in 2020. He was later awarded a University of Newcastle Vice-Chancellor's Scholarship and began his career in research and academia in 2021.
Grounded in cardio-oncology—the nexus of cardiovascular health and cancer—his research largely focusses on pharmacist-led models of care to better manage and mitigate the deleterious effects of cardiovascular disease secondary to cancer and its treatment; especially across transitions of care.
Joshua has established himself as a lead in cardio-oncology pharmacy within Australia, presenting his research both nationally and internationally. He currently serves as the Australian Governor for the International Society of Cardiovascular Pharmacotherapy and is an active member of the International Cardio-Oncology Pharmacist Working Group.
Joshua is a credentialled pharmacist who continues to work clinically through the provision of domiciliary medication management review services for his community.
Qualifications
- Doctor of Philosophy (Pharmacy), University of Newcastle
- Bachelor of Pharmacy with First Class Honours, University of Newcastle
Keywords
- Cardio-Oncology
- Heart Failure
- Immune Checkpoint Inhibitor
- Medication Managmenet
- Pharmacy
- Transition-of-Care
Languages
- English (Mother)
Fields of Research
| Code | Description | Percentage |
|---|---|---|
| 320101 | Cardiology (incl. cardiovascular diseases) | 25 |
| 321104 | Cancer therapy (excl. chemotherapy and radiation therapy) | 25 |
| 321403 | Clinical pharmacy and pharmacy practice | 50 |
Professional Experience
UON Appointment
| Title | Organisation / Department |
|---|---|
| Casual Academic | University of Newcastle School of Biomedical Sciences and Pharmacy Australia |
| Casual Web Learn Tutor Nursing Midwifery | University of Newcastle School of Nursing and Midwifery Australia |
Teaching
| Code | Course | Role | Duration |
|---|---|---|---|
| PHAR3203 |
Clinical Pharmacotherapy 3 School of Biomedical Science & Pharmacy, University of Newcastle |
Lab Demonstrator - Pharmacy | 1/1/2023 - 31/12/2025 |
| PHAR1101 |
Introduction to Pharmacy and Formulation Sciences School of Biomedical Science & Pharmacy, University of Newcastle |
Lab Demonstrator - Pharmacy | 8/7/2021 - 31/12/2025 |
| PHAR3104 |
Clinical Pharmacotherapy 2 School of Biomedical Science & Pharmacy, University of Newcastle |
Pharmacy Examiner | 31/1/2023 - 31/12/2025 |
| NURS6622 |
Clinical Practice B School of Nursing and Midwifery |
Examiner | 13/10/2022 - 31/12/2025 |
| PHAR2101 |
Dermatology and Topical Formulations School of Biomedical Science & Pharmacy, University of Newcastle |
Tutorial Facilitator | 26/8/2021 - 31/12/2025 |
Publications
For publications that are currently unpublished or in-press, details are shown in italics.
Journal article (10 outputs)
| Year | Citation | Altmetrics | Link | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
Bennetts JD, Robson C, Weismantel-Savage A, Mani J, Yu J, Robson L, Collins NJ, Williams TD, Sverdlov AL, Ngo DTM, 'Evaluation of a Nurse-Pharmacist Post-Discharge Telehealth Model of Care for People With Heart Failure', Heart, Lung and Circulation (2026)
|
||||||||||
| 2025 |
Bennetts JD, Sverdlov AL, Ngo DT, 'Cardiometabolic perturbations arising from treatment with novel anticancer therapies', Trends in Cardiovascular Medicine (2025) [C1]
|
||||||||||
| 2025 |
Bennetts JD, Williams TD, Beavers CJ, Moore HN, Robson C, Warner T, Dent S, Sverdlov AL, Ngo DTM, 'The cardio-oncology multidisciplinary team: beyond the basics', Cardio Oncology, 11 (2025) [C1]
|
||||||||||
| 2025 |
Butel-Simoes LE, Albayati A, Yu J, Quirk T, Sritharan S, French M, Bennetts JD, Ngo DTM, Sverdlov AL, 'Tyrosine kinase inhibitors - balancing the haemostatic scales: a review of associated thrombosis and bleeding', Journal of Thrombosis and Thrombolysis (2025) [C1]
|
Open Research Newcastle | |||||||||
| 2024 |
Bennetts J, White J, Croft H, Cooper J, McIvor D, Eadie N, Appay M, Sverdlov AL, Ngo D, 'Pharmacist-led medication management services: a qualitative exploration of transition-of-care cardiovascular disease patient experiences', BMJ OPEN, 14 (2024) [C1]
|
Open Research Newcastle | |||||||||
| Show 7 more journal articles | |||||||||||
Grants and Funding
Summary
| Number of grants | 4 |
|---|---|
| Total funding | $52,949 |
Click on a grant title below to expand the full details for that specific grant.
20251 grants / $16,226
Experiences relating to care and rehabilitation after treatment for cancer$16,226
Funding body: Hunter New England Local Health District
| Funding body | Hunter New England Local Health District |
|---|---|
| Project Team | Dr Allan Davies, Dr Joshua Bennetts, Mr Lloyd Butel Simoes, Dr Jie Yu |
| Scheme | John Hunter Hospital Charitable Trust Grant |
| Role | Investigator |
| Funding Start | 2025 |
| Funding Finish | 2025 |
| GNo | G2500608 |
| Type Of Funding | C2300 – Aust StateTerritoryLocal – Own Purpose |
| Category | 2300 |
| UON | Y |
20241 grants / $21,179
IMplementation and Prospective evAluation of dedicated Cardio-oncology services for prevention, monitoring and Treatment of CardioVascular Diseases in patients living with, through and beyond cancer.$21,179
Funding body: Hunter Medical Research Institute
| Funding body | Hunter Medical Research Institute |
|---|---|
| Project Team | Mr Joshua Bennetts, Dr Kristy Fakes |
| Scheme | Heart and Stroke Program | Infrastructure Funding Round |
| Role | Investigator |
| Funding Start | 2024 |
| Funding Finish | 2025 |
| GNo | |
| Type Of Funding | C2300 – Aust StateTerritoryLocal – Own Purpose |
| Category | 2300 |
| UON | N |
20231 grants / $5,060
Comorbidities associated with cardiovascular disease and death in patients receiving immune checkpoint inhibitors as part of their anticancer treatment: a retrospective study.$5,060
Funding body: Cancer Institute NSW
| Funding body | Cancer Institute NSW |
|---|---|
| Project Team | Mr Joshua Bennetts |
| Scheme | 2023 Travel Grant |
| Role | Lead |
| Funding Start | 2023 |
| Funding Finish | 2023 |
| GNo | |
| Type Of Funding | C2300 – Aust StateTerritoryLocal – Own Purpose |
| Category | 2300 |
| UON | N |
20221 grants / $10,484
Pharmacist reviews to reduce readmission rates and Improve adherence to guideline based therapy: A pilot study$10,484
Funding body: Hunter New England Local Health District
| Funding body | Hunter New England Local Health District |
|---|---|
| Project Team | Mr Joshua Bennetts, Dr Trent Williams, A/Prof Aaron Sverdlov, Mr Cameron Robson |
| Scheme | John Hunter Hospital Charitable Trust Grant |
| Role | Investigator |
| Funding Start | 2022 |
| Funding Finish | 2022 |
| GNo | |
| Type Of Funding | C2300 – Aust StateTerritoryLocal – Own Purpose |
| Category | 2300 |
| UON | N |
Dr Joshua Bennetts
Positions
Postdoctoral Researcher
School of Medicine and Public Health
College of Health, Medicine and Wellbeing
Research Assistant
School of Biomedical Sciences and Pharmacy
College of Health, Medicine and Wellbeing
Casual Web Learn Tutor Nursing & Midwifery
School of Nursing and Midwifery
College of Health, Medicine and Wellbeing
Casual Academic
School of Biomedical Sciences and Pharmacy
College of Health, Medicine and Wellbeing
Contact Details
| joshua.bennetts@newcastle.edu.au | |
| Phone | 0435943292 |
| Mobile | 0435943292 |
| Links |
Research Networks Research Networks |
